FMR LLC reports 8.8% stake in Immunocore
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
FMR LLC and Abigail P. Johnson report their beneficial ownership of Immunocore Holdings plc common stock on an amended Schedule 13G. FMR LLC reports beneficial ownership of 4,307,246 shares of common stock, representing 8.8% of the class. These shares are held with sole dispositive power and no shared voting or dispositive power.
Abigail P. Johnson is reported as having sole dispositive power over the same 4,307,246 shares, also representing 8.8% of the outstanding common stock, with no voting or shared dispositive power. One or more other persons have rights to receive dividends or sale proceeds from these securities, but no such person holds more than five percent of the class.
Key Figures
Key Terms
beneficially owned financial
sole dispositive power financial
Schedule 13G regulatory
percent of class financial
parent holding company regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake in Immunocore Holdings plc (IMCR) does FMR LLC report on this Schedule 13G/A?
How much Immunocore (IMCR) stock is attributed to Abigail P. Johnson in this filing?
What is the class and CUSIP of the Immunocore (IMCR) securities covered by this Schedule 13G/A?
Which subsidiaries are associated with the IMCR holdings reported by FMR LLC?
AI-generated analysis. How Rhea-AI works. Not financial advice.